The Discounted Cash Flow (DCF) valuation of China Resources Pharmaceutical Group Ltd (3320.HK) is 11.71 HKD. With the latest stock price at 4.89 HKD, the upside of China Resources Pharmaceutical Group Ltd based on DCF is 139.5%.
Based on the latest price of 4.89 HKD and our DCF valuation, China Resources Pharmaceutical Group Ltd (3320.HK) is a buy. buying 3320.HK stocks now will result in a potential gain of 139.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.0% | 7.1% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 8.05 - 17.48 | 11.71 |
| Upside | 64.7% - 257.4% | 139.5% |